NCT01737684
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
- Locations
-
Not specified
Clinical trial condition
Overactive Bladder
Explore clinical trials studying Overactive Bladder. Study availability and eligibility vary by location and protocol.
362 public trials
25 recruiting studies
Overactive Bladder trial results
NCT00425100
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
- Locations
-
- Pfizer Investigational Site Homewood, Alabama, United States
- Pfizer Investigational Site Huntsville, Alabama, United States
- Pfizer Investigational Site La Mesa, California, United States
- Pfizer Investigational Site Orangevale, California, United States
NCT00911937
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
- Locations
-
- Pfizer Investigational Site Mobile, Alabama, United States
- Pfizer Investigational Site Goodyear, Arizona, United States
- Pfizer Investigational Site Litchfield Park, Arizona, United States
- Pfizer Investigational Site Phoenix, Arizona, United States
NCT00943735
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
- Locations
-
Not specified
NCT02735499
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +11 more
- Locations
-
- Dept of Ob/Gyn, The Hospital of Vestfold Tønsberg, Norway
Completed
Study In Patients With Overactive Bladder Treated With Toviaz® After Failure Of Previous Therapy
NCT00691093
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +11 more
- Locations
-
- Pfizer Investigational Site ?a?a, Slovakia
- Pfizer Investigational Site Aa, Slovakia
- Pfizer Investigational Site Adca, Slovakia
- Pfizer Investigational Site B.Bystrica, Slovakia
Completed
Detrol Long Acting (LA) vs Estrace Vaginal Cream for the Treatment of Overactive Bladder Symptoms
NCT00465894
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
- Locations
-
Not specified
Completed
"The Effects of Caffeine on Overactive Bladder Symptoms and Mental Health in Postmenopausal Women"
NCT02180048
- Conditions
- Caffeine, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
- Locations
-
- Department of Urology, Loma Linda University Loma Linda, California, United States
NCT02568774
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
- Locations
-
- Shanghai TCM-INTEGRATED Hospital, Shanghai University of Traditional Chinese Medicine Shanghai, China
- Tung Wah Eastern Hospital Hong Kong
- Tung Wah Hospital Hong Kong
NCT02600715
- Conditions
- Cystitis, Cystitis, Interstitial, Female Urogenital Diseases, +19 more
- Locations
-
- Wichita Women's Pelvic Surgery Center at Associates in Women's Health Wichita, Kansas, United States
- University of Kansas School of Medicine - Wichita Wichita, Kansas, United States